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Abstract
Analyses of arsenic (As) species in tissues and body fluids of individuals chronically exposed to
inorganic arsenic (iAs) provide essential information about the exposure level and pattern of iAs
metabolism. We have previously described an oxidation state-specific analysis of As species in
biological matrices by hydride-generation atomic absorption spectrometry (HG-AAS), using
cryotrapping (CT) for preconcentration and separation of arsines. To improve performance and
detection limits of the method, HG and CT steps are automated and a conventional flame-in-tube
atomizer replaced with a recently developed multiple microflame quartz tube atomizer
(multiatomizer). In this system, arsines from AsIII-species are generated in a mixture of Tris-HCl
(pH 6) and sodium borohydride. For generation of arsines from both AsIII- and AsV-species, samples
are pretreated with L-cysteine. Under these conditions, dimethylthioarsinic acid, a newly described
metabolite of iAs, does not interfere significantly with detection and quantification of methylated
trivalent arsenicals. Analytical performance of the automated HG-CT-AAS was characterized by
analyses of cultured cells and mouse tissues that contained mono- and dimethylated metabolites of
iAs. The capacity to detect methylated AsIII- and AsV-species was verified, using an in vitro
methylation system containing recombinant rat arsenic (+3 oxidation state) methyltransferase and
cultured rat hepatocytes treated with iAs. Compared with the previous HG-CT-AAS design, detection
limits for iAs and its metabolites have improved significantly with the current system, ranging from
8 to 20 pg. Recoveries of As were between 78 and 117%. The precision of the method was better
than 5% for all biological matrices examined. Thus, the automated HG-CT-AAS system provides an
effective and sensitive tool for analysis of all major human metabolites of iAs in complex biological
matrices.
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Arsenic (As) occurs naturally in minerals and geological formations that compose Earth’s crust.
Inorganic arsenic (iAs) is the most abundant form of As in soil, underground aquifers and
surface water reservoirs.1 Chronic exposures to iAs in drinking water affect millions of people
worldwide. In some areas with high chronic exposure to iAs, prevalences of diseases (e.g. skin
lesions, diabetes, hypertension, or cancer) have reached epidemic proportions.2–4 Ingested
iAs that is readily absorbed from drinking water undergoes complex metabolic transformation
in human tissues. Metabolism of iAs involves sequential reactions in which AsV-species are
reduced to trivalency and AsIII-species undergo oxidative methylation, yielding methylated
arsenical containing pentavalent arsenic. Four methylated arsenicals have been identified as
major products of iAs metabolism in humans: methylarsonous acid (MAsIII), methylarsonic
acid (MAsV), dimethylarsinous acid (DMAsIII) and dimethylarsinic acid (DMAsV). These
methylated arsenicals and the iAs species, arsenate (iAsV) and arsenite (iAsIII), are consistently
detected in urine of individuals exposed to iAs in drinking water 5–10 and in cultures of human
hepatocytes treated in vitro with iAs.11 Another methylated arsenical, which contains
pentavalent arsenic, dimethythioarsinic acid (DMTA), has been identified as a metabolite in
urine of Bangladeshi women chronically exposed to iAs from drinking water.12
Evidence from laboratory studies suggest that a single enzyme, As (+3 oxidation state)
methyltransferase (AS3MT), catalyzes formation of both tri- and pentavalent MAs and DMAs
in the course of iAs metabolism13,14. Trivalent arsenicals are generally more toxic than
pentavalent arsenicals. In addition, MAsIII and DMAsIII are more toxic than either iAsV or
iAsIII in some biological systems15. Thus, the rate and the pattern of iAs metabolism that
determine the amounts and composition of iAs metabolites produced and retained in human
tissues are believed to play key roles in modulation of chronic and acute toxicities of iAs.
Comprehensive analysis of AsIII- and AsV-species in body fluids or tissues is an essential tool
for evaluation of the pattern of iAs metabolism in exposed individuals, and thus, for assessment
of risk of adverse health effects associated with iAs exposure. Analytical techniques for
determination of tri- and pentavalent metabolites of iAs are also required for laboratory studies
that examine metabolic conversion and modes of action for iAs and its metabolites in animal
and in vitro models.
Several techniques have successfully been used for oxidation-state specific speciation analysis
of As in biological matrices, including high-performance liquid chromatography (HPLC)-HG-
atomic fluorescence spectrometry (AFS),5–7 HPLC-inductively coupled argon plasma mass
spectrometry (ICP-MS),9,16 and pH-selective HG-atomic absorption spectrometry (AAS)
with cryotrapping (CT) and separation of arsines based on their boiling points.8,10,11 The
HPLC-based methods allow direct analysis of free AsIII- and AsV-species in human or animal
urine. However, application of these methods for speciation analysis of As in more complex
biological matrices requires acid digestion of samples which oxidizes all methylated AsIII-
species17,18 or laborious multi-step extraction of protein-bound arsenicals with As chelators.
19 By comparison, the pH-selective HG-CT-AAS is capable of direct oxidation-state specific
speciation analysis of As even in a relatively complex biological matrices (e.g., cell lysates)
without sample pretreatment.11 Thus, although less specific than HPLC-ICP-MS, HG-CT-
AAS has been used in laboratory studies of the formation of AsIII- and AsV-metabolites during
metabolism of arsenicals in cultured human and animal cells.15,20 However, utility of the
original HG-CT-AAS method8 was limited by its low sensitivity. The detection limit (DL) for
As species ranged from 1.1. to 6.5 ng ml−1. Largely manual operation also limited throughput
for this method. Although optimization of CT and of temperature gradient conditions improved
significantly DL of this method11, the procedure remained labor intensive.
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We have recently described an automated system for the oxidation state specific speciation
analysis of inorganic and methylated arsenicals by selective HG-CT-AAS with a multiatomizer
for arsine detection.21 This is a continuous flow system in which arsines from AsIII-containing
arsenicals are selectively generated in a mixture of Tris-HCl (pH 6) and sodium borohydride.
To allow arsine generation from both AsIII- and AsV-containing arsenicals, pentavalent
arsenicals are first reduced to trivalency by treatment with a reductant, L-cysteine (Cys). Thus,
two measurements are needed for each sample to determine the contents of AsIII-containing
species and AsIII+V species after treatment with Cys. The contents of AsV-containing species
are then calculated as a diffierence between the two measurements. This modified method has
lowered DL values for all relevant As species; automation of the CT step has improved sample
throughput. The present study tested analytical performance of the automated HG-CT-AAS,
using matrices generated in biological experiments, including mouse tissues and rat and human
cells. Results of these tests show that the optimized HG-CT-AAS is capable of analyzing As
species, including methylated trivalent arsenicals (MAsIII and DMAsIII) with DL values of 8
to 20 pg As that approach DL values described for ICP-MS systems. Thus, although this method
lacks the specificity that can be attained by HPLC-based analytical approaches, the automated
HG-CT-AAS system with a multiatomizer can be used as an efficient tool for a direct oxidation-
state specific speciation analysis of As in biological samples which would otherwise require
laborious extraction to preserve unstable methylated AsIII species.
Experimental
Instrumentation
Speciation analyses of As in biological matrices spiked with standards and in samples generated
in in vitro, cell culture, and animal experiments were performed using a PerkinElmer Model
5100 PC atomic absorption spectrometer equipped with FIAS 200 (PerkinElmer, Norwalk,
CT, USA) and coupled with the automated CT unit.21 An arsenic electrode-less discharge
lamp (System II, Perkin-Elmer) at 390 mA was used as the radiation source. The slit width was
0.7 nm. Deuterium background correction was applied. The total As was analyzed by graphite
furnace (GF)-AAS, using Perkin-Elmer model 5100 atomic absorption spectrometer equipped
with an autosampler.
Reagents
Arsenicals used as standards for HG-CT-AAS analysis included sodium arsenite (99% pure;
Sigma-Aldrich, St. Louis, MO), sodium arsenate (96%, Sigma), methylarsonic acid, disodium
salt (98%, Chem Service, West Chester, PA), and dimethylarsinic acid (98%, Strem Chemicals,
Inc., Newburyport, MA). MAsIII [(CH3AsIIIO)4], DMAsIII, iodide salt [(CH3)2AsIIII], and
trimethylarsine oxide [(CH3)3AsVO; TMAsVO] were synthesized by Professor William Cullen
(University of British Columbia, Vancouver, Canada).22 DMTA was prepared by Dr John T.
Creed (US EPA National Exposure Research Laboratory, Cincinnati, OH), as previously
described.23 The content of total As in all standards was determined by GF-AAS. Sodium
borohydride (NaBH4) was from EM Science (Gibbstown, NJ). Ultrapure phosphoric acid was
obtained from J. T. Baker (Phillipsburg, NJ). Ultra-pure Cys hydrochloride monohydrate was
purchased from Sigma and Tris-hydrochloride purchased from EMD Chemicals Inc.
(Gibbstown, NJ). All other chemicals used were the highest grade commercially available.
Cultured cells and treatments
Cultured cell lines used to prepare biological matrices for method validation or to generate
samples for As speciation analysis included human hepatocellular carcinoma (HepG2) cells
(HB-8065; American Type Culture Collection, Manassas, VA), SV-40 transformed normal
human urothelial (UROtsa) cells (gift from Dr Unimye, West Virginia University), and a clonal
UROtsa/F35 cell line that expresses rat AS3MT.20 These cell lines were cultured in 6-well
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plates (Costar Corning Incorporated, Corning, NY) in 2 ml of MEM medium per well (GIBCO,
BRL, Grand Island, NY) containing 10% fetal bovine serum (FBS, GIBCO), 50 U penicillin
ml−1 and 5 0 μg streptomycin ml−1). Primary cultures of hepatocyte from a 10 week old female
Sprague-Dawley rat (CellzDirect, Pittsboro, NC) were established in 6-well culture plates in
a supplemented Williams’ medium E (2 ml well−1). All cells were maintained in a humidified
atmosphere with 5% CO2 at 37 °C. In metabolic experiments, 70%-confluent cultures of
HepG2, UROtsa and UROtsa/F35 cells were incubated with 1 μM iAsIII for 24 h. Rat
hepatocytes were incubated with 0.1 or 1 μM of iAsIII for 2 or 6 h. After incubation, media
were collected and cells were lysed on ice for 5 min with cold 0.5% solution of Triton-X100
in deionized water. Media and cell lysates from control (untreated) cultures were spiked with
As standards and used for method validation. Media and cell lysates from cultures incubated
with iAsIII served as samples for speciation analysis by HG-CT-AAS.
Mice and treatments
Four week-old male weanling C57BL/6 mice were obtained from Jackson Laboratory (Bar
Harbor, ME, USA) and housed in polycarbonate cages with corn cob bedding in the University
of North Carolina Animal Facilities with a 12 h light/dark cycle at 22 ± 1 °C and 50 ± 10%
relative humidity. These facilities are accredited by the American Association for Accreditation
of Laboratory Animal Care. Mice were housed five per cage with free access to food (Lab Diet
5058, Nutrition International, Brentwood, MO) and drinking water without or with addition
of iAsIII (50 ppm As). After 8 weeks mice were euthanized, and dissected. Collected tissues
were snap frozen in liquid nitrogen and stored at −70 °C before analysis.
In vitro methylation system
In vitro methylation of iAsIII by recombinant rat AS3MT was performed as previously
described.11,24 Briefly, the reaction mixture (100 μl) contained 100 mM sodium phosphate
(pH 7.4), 100 mM Tris buffer (pH 7.4), 2 μM E. coli thioredoxin (Sigma), 1 mM S-
adenosylmethionine (AdoMet) (Sigma), 0.25 μM rat thioredoxin reductase (American
Diagnostica, Greenwich, CT), 300 μM NADPH (Sigma), 3 μM of iAsIII, and 2 μg of
recombinant rat AS3MT. The mixture was incubated in capped tubes at 37 °C for 1 h or
overnight.
Speciation analysis of As by HG-CT-AAS
Sample preparation and treatment—In vitro reaction mixtures, cell lysates and media
from cell cultures were analyzed without digestion or extraction. Mouse tissues were
homogenized in deionized water (1 : 20 w/v) and tissue homogenates were digested overnight
in 2 M ultrapure phosphoric acid (90 °C) as previously described.25 Phosphoric acid in digested
samples was neutralized by NaOH. For analysis of total iAs (iAsIII + iAsV), MAs (MAsIII +
MAsV) and DMAs (DMAsIII + DMAsV), samples were incubated with Cys hydrochloride (2%
Cys and 0.11 M HCl final concentrations; pH 1.5) for 70 min at room temperature. Preliminary
tests showed that time needed for the reduction of AsV to AsIII by Cys differs for various
AsV species. At least 60 min incubation was necessary for reduction and complete As recovery
of all AsV-species examined in this study. Trivalent arsenicals were analyzed directly without
pretreatment of samples with Cys.
HG and CT steps—An aliquot of a Cys-treated or untreated sample (500 μl each) was
injected into a flow of deionized water continuously mixed with a flow of 0.75 M Tris-HCl
buffer (pH 6) and a flow of 1% NaBH4 in 0.1% NaOH/0.02% antifoam B silicone emulsion.
The flow rate for each component (1 ml min−1) was controlled by a multi-channel FIAS
peristaltic pump. Arsines generated by reaction with NaBH4 and separated from the liquid
phase in a 50 ml gas–liquid separator were swept in a helium (76 ml min−1) and hydrogen (15
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ml min−1) stream into an automated CT unit. Design and operation of the CT unit were
described in detail in ref. 21. Briefly, the CT unit contained a 305 mm long glass U-tube (2.5
mm id) packed with 0.8 g of Chromosorb WAW-dimethyldichlorosilane 45/60 with 15% OV-3
(Supelco, Inc., Bellefonte, PA) and wrapped with a 1.6 Ω ft−1 Ni80/Cr20 wire (Omega
Engineering, Stamford, CT) providing a total resistance of 15% Ω. The U tube was inserted in
a sealed 300 mm long double-walled glass cylinder (40 mm id) with an inlet for liquid N2 at
the bottom and an outlet for N2 gas at the top. A FIAS-controlled solenoid valve (7/32″ inner
orifice, Omega Engineering, Stamford, CT) was connected to the outlet. The cylinder with U-
tube was placed in a 4.3 l Dewar flask filled with liquid N2. During the HG step, the solenoid
valve was open and the glass cylinder containing the U-tube was filled with liquid N2.
Following the HG reaction, the solenoid valve closed and the U tube was gradually heated to
approximately 150 °C by application of an electrical current to the Ni80/Cr20 wire. Expanding
N2 gas produced by heating displaced liquid N2 through the inlet at the bottom of the cylinder
into the Dewar flask. The heating also permitted boiling point separation of arsines trapped in
the U tube.
Detection and quantitation of As—Arsines released by heating were carried form the CT
unit in a flow of helium/hydrogen into a quartz multiatomizer placed in the optical axis of the
Perkin-Elmer 5100 PC atomic absorption spectrometer. The multiatomizer was electrically
heated to 900 °C with 35 ml min−1 of air as outer gas.26 Atomic absorption peaks corresponding
to arsine, methylarsine, dimethylarsine and tri-methylarsine were recorded during a 90 s
reading window. Identities of arsines generated from biological samples were confirmed by
spiking samples with As standards at several concentrations. Areas of individual peaks were
used for calculation of the contents of As species. The contents of AsIII-species were
determined directly from peaks detected after HG in the absence of Cys; the peaks detected
after HG from Cys-treated samples were used to determine the contents of AsIII+V-species.
The contents of pentavalent As species were calculated as a diffierence between the contents
of AsIII+V- and AsIII-species.
Calibration—Five-point calibration curves (0.1, 0.5, 1, 2 and 5 ng As ml−1) were generated
for each of the As standards. Calibration curves for analysis of AsIII+V-species in Cys-treated
biological samples were generated using pentavalent As standards spiked into the
corresponding matrices and pretreated for 70 min with 2% Cys. Trivalent As standards spiked
into the same matrices were used to generate calibration curves for analysis of AsIII-containing
species in the absence of Cys. The concentration of total speciated As for each biological
sample was calculated as a sum of concentrations of iAsIII, iAsV, MAsIII, MAsV, DMAsIII,
DMAsIII, and TMAsVO.
Analysis of total As
To calculate recovery of As from HG-CT-GC-AAS analysis of mouse tissues, total As contents
in tissues were determined by GF-AAS. For this analysis, tissues were digested, using a Model
MARS 5 microwave and following the 3052 EPA method with some modifications. Briefly,
0.1 g of tissue was completely wet digested in 70% nitric acid in a total volume of 10 ml. One
milliliter of the digestate was diluted with 20% nitric acid to a final volume of 5 ml. An aliquot
of 40 μl of this solution was injected into the GF along with 10 μl of a chemical modifier (5
μg of palladium and 5 μg of magnesium nitrate in 2% nitric acid). The GF program included
a drying step at 130 °C for 40 s, ashing step at 1300 °C for 40 s, and atomization step at 2300
°C for 3 s. A four-point calibration curve (0.5, 1, 2 and 5 ng As ml−1) was generated for
iAsV standard in 10% HNO3. Percentage recovery of As for each tissue was calculated from
the ratio of the total speciated As concentration (determined by HG-CT-GC-AAS) and the total
As concentration (determined by GF-AAS).
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Speciation analysis of As in biological matrices spiked with As standards
The first step examined the capacity of the newly configured HG-CT-AAS system to speciate
As in cell lysates and culture media spiked with mixtures of As standards. The evaluation
focused on As species identified in earlier epidemiological and laboratory based studies as
significant metabolites of iAs in humans (iAsIII, iAsV, MAsIII, MAsV, DMAsIII, and
DMAsV). These experiments used cell lysates and FBS-containing medium from control
(untreated) HepG2 cultures. Fig. 1 shows chromatograms from HG-CT-AAS analyses of
mixtures of AsV- and AsIII-standards in cell lysates. As described above, cell lysates spiked
with AsV-standards were treated with Cys before HG. Complete baseline separation of arsine,
methyl-arsine, and dimethylarsine was achieved. Similar signals were obtained for standards
spiked into the culture medium (data not shown). Average retention times in seconds (mean ±
SD, n = 6) for arsines generated from a mixture of trivalent arsenic standards in lysates and
culture medium were 7.3 ± 0.09 for arsine, 30.5 ± 0.63 for methylarsine, and 39.9 ± 0.58 for
dimethylarsine. Average retention times for arsines generated from a mixture of pentavalent
arsenic standards in lysates and culture medium treated with Cys were 7.8 ± 0.11 for arsine,
30.0 ± 0.38 for methylarsine, and 39.3 ± 0.40 for dimethylarsine. Calibration curves for AsV-
and AsIII-standards were linear over the range of 0.1 to 5 ng As ml−1 (Table 1) with statistically
significant correlations between the signal and As concentration (R2 > 0.99, p < 0.001). Slopes
of calibration curves were similar (0.84 to 1.08) despite diffierences in the oxidation state of
As or the biological matrix (Table 1). This suggests that efficiencies for HG and atomization
of hydrides were similar for all arsenicals tested. The DL for each As species and each matrix
was determined as 3σn−1 for the area of blank (n = 10) at the corresponding retention times.
HG from blanks was performed in the absence or presence of Cys to determine DL values for
tri- and pentavalent arsenicals, respectively. The DL values ranged from 9 to 20 pg for trivalent
species and from 8 to 20 pg for pentavalent species (Table 1). Precision of the method expressed
as relative SD for arsenical standards spiked in cell lysate and culture medium at final
concentrations of 0.25, 0.5, and 1 ng As was always better than 4%. Precision for a final
concentration of 0.05 ng As ranged from 5.8 to 13.4%.
Efficiencies of HG for DMTA
To determine whether DMTA, a sulfur-containing metabolite of iAs, interferes with analysis
of DMAsIII or DMAsV by HG-CT-AAS, we compared efficiencies of HG and retention times
for the three dimethyl-As species. Cell lysates and medium from HepG2 cultures were spiked
with DMTA, DMAsIII or DMAsV (0.25 or 2.5 ng each) and HG was carried out in the presence
or absence of Cys. Fig. 2 shows chromatograms for samples spiked with 2.5 ng of each
dimethyl-As standard. Similar retention times were recorded for dimethylarsine generated from
each of the three standards. Relative efficiencies of HG for DMAsV and DMTA were calculated
as:
Relative efficiencies of HG in the absence of Cys ranged from 2.3 to 3.5% for DMAsV and
from 4 to 11.7% for DMTA (Table 2). Notably, HG generation was more efficient for samples
spiked with 0.25 as compared to 2.5 ng DMTA. In the presence of Cys, the efficiency of HG
for DMAsV increased to 88 to 108%, but remained relatively low for DMTA (15.4 to 37%).
Speciation analysis of As in cells exposed to iAsIII in culture
Biological samples for As speciation analysis by HG-CT-AAS were prepared by exposing
cultured cells to 1 μM iAsIII for 24 h. HepG2 and UROtsa/F35 cells that express AS3MT and
methylate iAsIII 20,27 were used in these experiments. The parental UROtsa cell line that neither
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expresses AS3MT nor methylates iAsIII 20 was used as a non-methylating control. Because
MAsIII and DMAsIII produced by methylating cells may oxidize during the 24 h exposure, all
cell lysates and media were pretreated with Cys before HG. Calibration curves for pentavalent
As standards spiked in cell lysates or media from control HepG2 and UROtsa/F35 cultures that
were not exposed to iAsIII were used to quantify analyses; all standards were treated with Cys
before HG. Table 3 shows total iAs, MAs, and DMAs detected in media and cell lysates and
calculated recoveries of the known amounts of iAsIII added into the cultures. Identities of As
species were confirmed by spiking aliquots of samples with As standards. As expected,
significant amounts of MAs and DMAs were found in HepG2 and UROtsa cultures exposed
to iAsIII. MAs and DMAs represented, respectively 12.3% and 1.8% of total speciated As in
HepG2 cells as compared to 1.9% and 41.7% of total speciated As in UROtsa/F35 cells.
Methylated As species were not found in UROtsa cells. Recoveries of As ranged from 88 to
98%. No As species were detected in control cell cultures that were not exposed to iAs.
Speciation of As in tissues of mice exposed to iAsIII in drinking water
HG-CT-AAS was also used to analyze As species in the liver and quadriceps muscle of mice
exposed to 50 ppm iAsIII in drinking water for 8 weeks. Because digestion in phosphoric acid
oxidizes all AsIII-species in tissues to pentavalency, digestates were treated with Cys before
analysis. Calibration curves were generated for pentavalent As standards prepared in
phosphoric acid. In order to match the treatment of tissues, all standards were incubated at 90
°C overnight and treated with Cys before HG. Consistent with results of our previous studies,
11 treatment with phosphoric acid did not result in demethylation of MAsV or DMAsV. Slopes
of the calibration curves for iAsV, MAsV and DMAsV were 1.04, 0.99 and 1.03, respectively.
These analyses found that the average concentration of total speciated As in liver was about
two times greater than that in muscle (Table 4). In both tissues, DMAs (DMAsIII+V) was the
major metabolite, representing 53.9% and 74.2% of total speciated As, respectively. On
average, iAs (iAsIII+V) and MAs (MAsIII+V) represented, respectively 29.4% and 16.5% of
total speciated As in the liver as compared to 13.8% and 11.8% in the muscle. To evaluate
recoveries of As by HG-CT-AAS analysis, total As contents were determined by GF-AAS,
using aliquots of tissues digested in nitric acid. Average recovery was 110% for quadricep and
105% for liver. The precision of the HG-CT-AAS analysis calculated as relative SD for three
concentrations of iAsV, MAsV and DMAsV standards in phosphoric acid (0.25, 0.5, and 1 ng;
n = 5) ranged from 1.3 to 4.4%. Notably, small amount of iAs was detected in the ultrapure
phosphoric acid (126 pg ml−1) used for tissue digestion.
Oxidation state specific speciation analysis of As in biological samples
Samples for oxidation-state specific analyses of As species were generated using an in vitro
assay system in which iAsIII was methylated by recombinant rat AS3MT and cultured rat
hepatocytes exposed to iAsIII. Calibration curves were generated for each of these systems
using tri- and pentavalent As standards spiked to the corresponding biological matrices,
including the in vitro assay mixture and cell lysates and medium from a control hepatocyte
culture that was not exposed to As. Biological matrices spiked with pentavalent As standards
were treated with Cys before HG. Slopes of these calibration curves were similar to those
reported in Table 1. Because trimethyl-As species are final products of iAs methylation by rat
AS3MT,28 TMAsVO was used as an additional As standard for these analyses.
Fig. 3 shows chromatograms for analysis of As species in the in vitro assay mixture after a 1
h incubation with 3 μM iAsIII. In addition to peaks of arsine, methylarsine and dimethylarsine,
a peak with a retention time corresponding to trimethylarsine was detected in reaction mixtures
analyzed directly and in mixtures pretreated with Cys in which the temperature gradient and
gas flow were modified to improve separation. Table 5 summarizes these analyses. All trivalent
and pentavalent arsenic containing species, except MAsIII, were detected in reaction mixtures
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after a 1 h incubation. After overnight incubation, practically all iAsIII was methylated.
TMAsVO was the major methylated metabolite found in reaction mixtures, accounting 28.9%
and 80.3% of the total speciated As after 1 h and overnight incubation, respectively. Notably
MAsIII was not detected at either incubation time. About 100% of As added into the reaction
mixture was recovered after 1 h incubation. In contrast, As recovery after overnight incubation
was only 73%.
Table 6 shows As species detected in cultured rat hepatocytes exposed to 0.1 and 1 μM
iAsIII for 2 or 6 h. Fig. 4 shows chromatograms for arsines generated from lysates and medium
from cultures exposed for 2 h to 1 μM iAsIII. These short exposure times were chosen to
minimize oxidation of methylated AsIII-species formed during methylation of iAs. Both tri-
and pentavalent MAs and DMAs were found in lysates and culture media under these
conditions. DMAsV was the major methylated metabolite for all exposure times and exposure
levels. TMAsVO was not detected in either lysates or culture media. After a 2 h incubation,
summed methylated metabolites accounted for about 74.3% and 39.5% of total speciated As
in cultures exposed to 0.1 or 1 μM iAsIII. After 6 h, summed methylated metabolites accounted
for 96.7% and 83.2% in cultures at 0.1 and 1 μM iAsIII, respectively. Recoveries of As ranged
from 78% to 117%.
Discussion
HG-CT-AAS has played a key role in providing evidence for the formation of toxic and
potentially carcinogenic methylated trivalent arsenicals, MAsIII and DMAsIII, in the pathway
for methylation of iAs in humans.8,10,11,20,27 The current work describes refinement of HG-
CT-AAS in which the HG and CT steps are automated and a multiatomizer is used to improve
DL. These modifications increase analytical throughput and markedly improve DL values for
all metabolites of iAs commonly found in human urine. DL values for these arsenicals in
relatively complex biological matrices, cell lysates and culture media, range from 8 to 20 pg
(i.e., 16 to 40 pg ml−1 for a 0.5 ml sample loop) and are about an order of magnitude lower
that those we have reported for a manual HG-CT-AAS system equipped with a conventional
atomizer (140 to 400 pg).11 These DL are comparable to DL values reported for most HPLC-
AFS or HPLC-ICP-MS techniques often used for oxidation state specific analysis of As in
biological samples.9,16,29–31 In addition, because slopes of the calibration curves for tri- and
pentavalent iAs, MAs and DMAs spiked to cell lysates or culture media are very similar,
calibration for a single As-species is sufficient for quantification. However, further
optimization and validation of the HG-CT-AAS protocol may be needed for the oxidation state
specific analyses of As species in other biological matrices.
The average retention times for individual arsines described above are specific for the
instrumentation used in this study. These retention times depend on a variety of factors,
including interferences associated with specific biological matrices, the size of U-tube, the
temperature gradient used to release arsines from the cryotrap, or on flow rates of the carrier
gases. In addition, the separation of arsines depends in part on chemical properties of the
absorbent filled in the U-tube. Matousek et al.21 have shown that gas chromatography on
Chromosorb WAW-dimethyldichlorosilane contributes to the separation of arsines during the
heating step. Thus, it is essential that key parameters affecting arsine separation are optimized
for each specific HG-CT-AAS system. Proper standards should be used to confirm identities
of arsines released from the cryotrap. This procedure must be repeated during the analyses and
specifically, every time key instrumental parts or parameters are modified. Users should be
also aware of potential problems associated with memory of the HG-CT-AAS system. In our
laboratory, small amounts of dimethylarsine were often detected in blanks run after DMAs-
rich biological samples, indicating that dimethylarsine absorbs in the surface of the tubing or
in the CT unit. In most cases, a rerun of a multiple blanks completely cleaned up the system.
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Although TMAsO is not a major metabolite of iAs in humans, it is a product of iAs methylation
by rat AS3MT28 and is found in urine of rats exposed to iAs or DMAsV.32–34 Here, TMAsO
was identified as a major metabolite of iAs in an in vitro assay mixture in which methylation
of iAs was catalyzed by recombinant rat AS3MT. Notably, low As recovery (72.3%) after the
overnight incubation of the assay mixture is consistent with formation of volatile
trimethylarsine, the final product of in vitro methylation of iAs by rat AS3MT. A similar As
recovery (72.5%) was reported for an in vitro methylation system containing 10 μM iAsIII,
recombinant rat AS3MT (5 μg), AdoMet, and a synthetic reductant, tris(2-carboxylethyl)
phosphine (TCEP), after a 16 h incubation at 37 °C.35 Analysis of the gaseous phase of this
system detected a significant amount of trimethylarsine. By comparison, the absence of
TMAsO as a product of iAs methylation by cultured primary rat hepatocytes was likely due to
a relatively high intracellular concentration of glutathione. Glutathione has been shown to
inhibit the formation of both TMAsO and trimethylarsine by recombinant AS3MT.35 Previous
work using the automated HG-CT-AAS21 has shown that separation of dimethylarsine and
trimethylarsine generated from aqueous solutions of DMAsV and TMAsO depends on the size
of the U tube and the temperature gradient applied during the heating step. In fact, a complete
separation was achieved only after heating was interrupted to delay release of trimethylarsine.
In the current study using a similarly designed automated HG-CT-AAS instrumentation and
similar heating program, a complete separation of dimethylarsine and trimethylarsine
generated from biological matrices was achieved only after HG in the absence of Cys. However,
the broad peak corresponding to trimethylarsine (Fig. 3a) could be a source of errors during
the signal quantification. Thus, although the current system represents an improved tool for
analysis of the common human metabolites of iAs, it requires further optimization for
quantitative analysis of TMAsO, the metabolite of iAs in rats.
Despite a significant improvement for DL values, the limited specificity of the HG-CT-AAS
system remains a potential problem. This method detects arsines generated from arsenicals
during the HG reaction, but provides only limited information about the chemical nature of
these arsenicals. In addition, some arsenicals commonly found in biological matrices (e.g.,
arsenocholine or arsenobetaine) cannot produce arsines in the reaction with sodium
borohydride, and thus cannot be detected by HG-CT-AAS. In our laboratory, HG-CT-AAS
has been used specifically for examination of iAs metabolism in well-defined biological
systems in which only the HG-active tri- and pentavalent MAs, and DMAs and pentavalent
TMAsVO are formed in the process of AS3MT-catalyzed methylation and in which the
presence of other HG-active or HG-resistant forms of As is not expected. Indeed, high As
recoveries from these systems suggest that all or most As species present were accounted for.
Under these conditions, a speciation error can occur only if an unknown metabolite of iAs with
a HG activity similar to those of the known metabolites is formed. Several recent reports have
suggested that sulfur-containing As species, specifically DMTA and dimethyldithioarsinic
acid, are products of iAs metabolism in mammals.12,36,37 DMTA was found in a wide range
of concentrations in urines collected from residents of arseniasis endemic areas of Bangladesh
who are exposed to iAs in drinking water.12 Because DMTA forms dimethylarsine in reaction
with NaBH4,37 the presence of DMTA in biological samples may interfere with HG-CT-AAS
analysis of DMAsIII and/or DMAsV. The present study examined the relative HG efficiencies
for DMTA, DMAsIII and DMAsV. Our data show that HG from Tris buffer (pH 6) in the
absence of Cys was rather inefficient for both DMAsV and DMTA as compared to DMAsIII.
In contrast, the efficiency of HG for DMTA increased in samples pretreated with Cys, reaching
up to 35% of that for DMAsIII or DMAsV (Table 2). The recoveries of As in biological samples
generated in this study, including mouse tissues, cultured cells or in vitro methylating systems,
ranged from 78 to 117%. Lower recoveries in some of these samples might indicate the
presence of small amounts of DMTA or As species other than tri- and pentavalent iAs, MAs
or DMAs. These findings are consistent with the identity of DMAsIII as a product of iAs
metabolism, not as an analytical artifact as has been recently suggested.12,38
Hernández-Zavala et al. Page 9













In summary, the automated HG-CT-AAS equipped with the multiatomizer represents an
effiective and highly sensitive method for the oxidation state specific analysis of common
human metabolites of iAs, including iAsIII, iAsV, MAsIII, MAsV, DMAsIII, and DMAsV. The
advantage of this system is that even more complex biological samples (e.g., cell lysates of
serum-containing tissue culture media) that contain protein-bound arsenicals can be analyzed
directly without prior extraction or separation, thus preserving the oxidation state of AsIII in
unstable methylated species. Importantly, the presence of DMTA does not significantly
interfere with analysis of DMAsIII, one of the most toxic and potentially carcinogenic products
of iAs metabolism in humans. However, because of its limited specificity, HG-CT-AAS alone
is not suitable for a comprehensive analysis of environmental or biological samples which
contain HG-resistant As species or As species with unknown HG activity.
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Separation and detection of arsine (A), methylarsine (B) and dimethylarsine (C) generated from
HepG2 cell lysates spiked with mixtures of standards: (a) iAsIII, MAsIII and DMAsIII (0.5 ng
As each) or (b) iAsV, MAsV and DMAsV (0.5 ng As each). HG was carried out in cell lysates
directly (a) or after pretreatment with Cys (b).
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HG efficiencies for dimethyl-As species: Detection of dimethylarsine generated from HepG2
cell lysates (a,b) or culture media (c,d) spiked with DMAsIII, DMAsV or DMTA (2.5 ng As
each). HG was carried out in cell lysates directly (a,c) or after pretreatment with Cys (b,d).
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The oxidation state specific analysis of metabolites of iAsIII produced in an in vitro reaction
catalyzed by rat AS3MT: The reaction mixture (100 μl) containing 100 mM sodium phosphate
(pH 7.4), 100 mM Tris buffer (pH 7.4), 2 μM E. coli thioredoxin, 1 mM S-adenosylmethionine,
0.25 μM rat thioredoxin reductase, 300 μM NADPH, 3 μM of iAsIII, and 2 μg of recombinant
rat AS3MT was incubated at 37 °C for 60 min. Aliquots of the mixture were analyzed by HG-
CT-AAS before and after pretreatment with Cys (—). Identities of spectral peaks were
confirmed, using aliquots of the reaction mixture spiked with (a) iAsIII, MAsIII, DMAsIII, and
TMAsO (0.5 ng each) or (b) iAsV, MAsV, DMAsV, and TMAsO (2.5 ng As each) (—). Peaks:
A, arsine; B, methylarsine; C, dimethylarsine; D, trimethylarsine.
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Speciation analysis of As in primary culture of rat hepatocytes exposed for 2 h to 1 μM
iAsIII: HG was carried out in cell lysates (a,b) and culture media (c,d) before (a,c) or after (b,d)
pretreatment with Cys. Peaks: A, arsine; B, methylarsine; C, dimethylarsine. (Note: Samples
were diluted in 10 or 20 volumes of deionized water prior to analysis in the absence or presence
of Cys, respectively.)
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Table 2
Relative efficiencies of HG for DMAIII, DMAV and DMTA spiked into HepG2 cell lysate or culture medium
HG efficiency (%)b
Cysa Biological matrices Spike/ng As DMAV DMTA
− Cell lysate 0.25 3.5 ± 0.1 10.0 ± 0.9
− Media 0.25 2.3 ± 0.2 11.7 ± 0.6
− Cell lysate 2.5 3.5 ± 0.1 5.7 ± 0.04
− Media 2.5 3.0 ± 0.2 4.0 ± 0.1
+ Cell lysate 0.25 104.6 ± 2.9 36.7 ± 3.6
+ Media 0.25 88.4 ± 0.03 15.4 ± 0.1
+ Cell lysate 2.5 108.1 ± 0.7 18.0 ± 0.1
+ Media 2.5 94.1 ± 1.3 16.7 ± 1.7
a
HG from matrices spiked with arsenicals was carried out with or without pretreatment with 2% Cys for 70 min.
b
The relative efficiency was calculated as: [peak area for DMAsV (or DMTA)/peak area for DMAsIII] × 100%; mean ± SD for 3 measurements are
shown for each condition.
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